Savara (SVRA) Other Accumulated Expenses (2012 - 2019)

Savara (SVRA) reported Other Accumulated Expenses of $5000.0 for Q2 2019, down 87.8% on a QoQ basis from $41000.0 in Q1 2019.

Savara (SVRA) has 8 years of Other Accumulated Expenses data on file, last reported at $5000.0 in Q2 2019.

  • Quarterly Other Accumulated Expenses changed N/A year-over-year to $5000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $5000.0 (changed N/A YoY) and the FY2018 annual result came in at $41000.0, up 485.71% from the prior year.
  • Other Accumulated Expenses retreated to $5000.0 in Q2 2019 per SVRA's latest filing, from $41000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $438000.0 in Q1 2016 and bottomed at $5000.0 in Q2 2019.
  • The 5-year median for Other Accumulated Expenses is $253500.0 (2015), against an average of $204928.6.
  • The widest annual swing landed in 2017, when Other Accumulated Expenses sank 96.74%; it then jumped 485.71% in 2018.
  • Tracing SVRA's Other Accumulated Expenses over 5 years: stood at $254000.0 in 2015, then tumbled by 81.5% to $47000.0 in 2016, then tumbled by 85.11% to $7000.0 in 2017, then jumped by 485.71% to $41000.0 in 2018, then plunged by 87.8% to $5000.0 in 2019.
  • Per Business Quant, the three latest SVRA Other Accumulated Expenses figures stand at $5000.0 (Q2 2019), $41000.0 (Q1 2019), and $41000.0 (Q4 2018).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Savara 1.30 Bn 1.30 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2019 5,000.00
Mar 31, 2019 41,000.00
Dec 31, 2018 41,000.00
Dec 31, 2017 7,000.00
Jun 30, 2017 11,000.00
Mar 31, 2017 253,000.00
Dec 31, 2016 47,000.00
Sep 30, 2016 302,000.00
Jun 30, 2016 337,000.00
Mar 31, 2016 438,000.00
Dec 31, 2015 254,000.00
Sep 30, 2015 350,000.00
Jun 30, 2015 436,000.00
Mar 31, 2015 347,000.00
Dec 31, 2014 242,000.00
Sep 30, 2014 257,213.00
Jun 30, 2014 215,582.00
Mar 31, 2014 95,544.00
Dec 31, 2013 221,000.00
Sep 30, 2013 325,944.00
Dec 31, 2012 80,168.00